Revolution Medicines, Inc. (RVMD) › Capital ExpendituresRevolution Medicines, Inc. (RVMD) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2018: $1.50M2019: $2.59M2020: $2.93M2021: $6.53M2022: $10.82M2023: $7.73M2024: $10.31M2025: $15.99M$15.99M2018Capital Expenditures (USD)2025Fiscal YearCapital ExpendituresChange YoY2025$15.99M+55.1%2024$10.31M+33.4%2023$7.73M-28.5%2022$10.82M+65.7%2021$6.53M+122.6%2020$2.93M+13.3%2019$2.59M+72.7%2018$1.50M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share